Empfehlung
9,0
Stark Verkaufen
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
39.9
5 neu, 3 erhöht, -18417K $ netto
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,72% (Stand: 28.02.2026)
Score-Verlauf (90 Tage)
Stammdaten
Unternehmen
| Name | Valneva SE |
|---|---|
| Ticker | VALN |
| CIK | 0001836564 |
Branche
| SIC-Code | 2836 |
|---|---|
| Beschreibung | Biological Products, (No Diagnostic Substances) |
Wertpapier
| CUSIP | 92025Y103 |
|---|---|
| ISIN | US92025Y1038 |
| Typ | ADR |
| Titel | VALNEVA SE FUNSPONSORED ADR 1 ADR REPS 2 ORD SHS |
Status
| Zuletzt geprüft | 2026-03-20 12:32:30.203806 |
|---|
Fondsaktivität (letzte 3 Quartale)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| Novo Holdings A/S | 2,305,000 | 2,345,000 | -40,000 | 20,330,100 | Reduziert | -1,7% | |
| Frazier Life Sciences Management, L.P. | 2,291,666 | 2,291,666 | 0 | 20,212,494 | Unverändert | 0,0% | |
| GENERAL AMERICAN INVESTORS CO INC | 354,361 | 354,361 | 0 | 3,125,464 | Unverändert | 0,0% | |
| WELLS FARGO & COMPANY/MN | 123,463 | 153,990 | -30,527 | 1,088,944 | Reduziert | -19,8% | |
| MARSHALL WACE, LLP | 31,211 | 0 | 31,211 | 380,776 | Neu | +100,0% | |
| MORGAN STANLEY | 42,981 | 32,987 | 9,994 | 379,092 | Aufgestockt | +30,3% | |
| VSM Wealth Advisory, LLC | 9,000 | 4,000 | 5,000 | 109,800 | Aufgestockt | +125,0% | |
| XTX Topco Ltd | 10,634 | 0 | 10,634 | 93,792 | Neu | +100,0% | |
| JPMORGAN CHASE & CO | 9,396 | 10,179 | -783 | 82,873 | Reduziert | -7,7% | |
| Marex Group plc | 11,300 | 0 | 11,300 | 64,071 | Neu | +100,0% | |
| China Universal Asset Management Co., Ltd. | 5,000 | 0 | 5,000 | 44,100 | Neu | +100,0% | |
| GAMMA Investing LLC | 1,857 | 2,117 | -260 | 16,379 | Reduziert | -12,3% | |
| RHUMBLINE ADVISERS | 1,763 | 218 | 1,545 | 15,549 | Aufgestockt | +708,7% | |
| OSAIC HOLDINGS, INC. | 1,555 | 555 | 1,000 | 13,715 | Aufgestockt | +180,2% | |
| Ridgewood Investments LLC | 550 | 0 | 550 | 3,119 | Neu | +100,0% | |
| UBS Group AG | 203 | 472 | -269 | 1,790 | Reduziert | -57,0% | |
| EverSource Wealth Advisors, LLC | 98 | 100 | -2 | 864 | Reduziert | -2,0% | |
| Clearstead Advisors, LLC | 48 | 0 | 48 | 427 | Neu | +100,0% | |
| Smartleaf Asset Management LLC | 43 | 0 | 43 | 359 | Neu | +100,0% | |
| RAYMOND JAMES FINANCIAL INC | 41 | 0 | 41 | 232 | Neu | +100,0% | |
| Allworth Financial LP | 7 | 7 | 0 | 62 | Unverändert | 0,0% | |
| Activest Wealth Management | 1 | 1 | 0 | 9 | Unverändert | 0,0% |
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Fail-to-Deliver (6 Monate)
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-02-27 | 2.092 | 10,91 | 22.824 |
| 2026-02-25 | 820 | 11,99 | 9.832 |
| 2026-02-24 | 25.452 | 11,44 | 291.171 |
| 2026-02-23 | 4.007 | 10,98 | 43.997 |
| 2026-02-20 | 1.278 | 10,56 | 13.496 |
| 2026-02-18 | 143 | 10,87 | 1.554 |
Top-Fondshalter (aktuelles Quartal)
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| Novo Holdings A/S | 2,305,000 | 20,330,100 | 44.77 |
| Frazier Life Sciences Management, L.P. | 2,291,666 | 20,212,494 | 44.52 |
| GENERAL AMERICAN INVESTORS CO INC | 354,361 | 3,125,464 | 6.88 |
| WELLS FARGO & COMPANY/MN | 123,463 | 1,088,944 | 2.40 |
| MORGAN STANLEY | 42,981 | 379,092 | 0.83 |
| XTX Topco Ltd | 10,634 | 93,792 | 0.21 |
| JPMORGAN CHASE & CO | 9,396 | 82,873 | 0.18 |
| China Universal Asset Management Co., Ltd. | 5,000 | 44,100 | 0.10 |
| GAMMA Investing LLC | 1,857 | 16,379 | 0.04 |
| RHUMBLINE ADVISERS | 1,763 | 15,549 | 0.03 |
| OSAIC HOLDINGS, INC. | 1,555 | 13,715 | 0.03 |
| UBS Group AG | 203 | 1,790 | 0.00 |
| EverSource Wealth Advisors, LLC | 98 | 864 | 0.00 |
| Clearstead Advisors, LLC | 48 | 427 | 0.00 |
| Smartleaf Asset Management LLC | 43 | 359 | 0.00 |
| Allworth Financial LP | 7 | 62 | 0.00 |
| Activest Wealth Management | 1 | 9 | 0.00 |